Pleiotropic Effects of Interleukin‐6 in a “Two‐Hit” Murine Model of Acute Respiratory Distress Syndrome
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Patients with acute respiratory distress syndrome (ARDS) exhibit elevated levels of interleukin‐6 (IL‐6), which correlate with increased morbidity and mortality. The exact role of IL‐6 in ARDS has proven difficult to study because it exhibits either pro‐ or anti‐inflammatory actions in mouse models of lung injury, depending on the model utilized. In order to improve understanding of the role of this complex cytokine in ARDS, we evaluated IL‐6 using the clinically relevant combination of lipopolysaccharide (LPS) and ventilator‐induced lung injury (VILI) in IL‐6−/–mice. Bronchoalveolar lavage fluid (BAL), whole‐lung tissue, and histology were evaluated for inflammatory markers of injury. Transendothelial electrical resistance was used to evaluate the action of IL‐6 on endothelial cells in vitro. In wild‐type mice, the combination model showed a significant increase in lung injury compared to either LPS or VILI alone.IL‐6−/–mice exhibited a statistically significant decrease in BAL cellular inflammation as well as lower histologic scores for lung injury, changes observed only in the combination model. A paradoxical increase in BAL total protein was observed in IL‐6−/–mice exposed to LPS, suggesting that IL‐6 provides protection from vascular leakage. However, in vitro data showed that IL‐6, when combined with its soluble receptor, actually caused a significant increase in endothelial cell permeability, suggesting that the protection seen in vivo was likely due to complex interactions of IL‐6 and other inflammatory mediators rather than to direct effects of IL‐6. These studies suggest that a dual‐injury model exhibits utility in evaluating the pleiotropic effects of IL‐6 in ARDS on inflammatory cells and lung endothelium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212 · cited 1×
“inflammatory effects of IL-6, which occur in a manner that is dependent on the type of signaling pathway utilized.(4,8)”
BackgroundImpaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706
Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome
PARK, W. Y., GOODMAN, R. B., STEINBERG, K. P., RUZINSKI, J. T., RADELLA, F., PARK, D. R., PUGIN, J., SKERRETT, S. J., HUDSON, L. D., & MARTIN, T. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104013 · Cited by 547
Interleukin-6 signalling: More than Jaks and STATs
Eulenfeld, R., Dittrich, A., Khouri, C., Müller, P. J., Mütze, B., Wolf, A., & Schaper, F. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.010 · Cited by 171
Cited by
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708
The molecular virology of coronaviruses
Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J. M., & Glaunsinger, B. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013930 · Cited by 525
Harrell, C. R., Markovic, B. S., Fellabaum, C., Arsenijevic, N., Djonov, V., & Volarevic, V. (2020) · BioFactors · doi:10.1002/biof.1587 · Cited by 106
“The highest production of IL-1Ra by lunginfiltrated MSCs was observed 72 hr after lung injury and was mainly triggered by IL-6, released from lunginfiltrated neutrophils and alveolar macrophages.(53,56,57) Importantly, as revealed by Xu and colleagues, MSCderived IL-1Ra creates “positive autocrine loop” in population…”
BackgroundQuijada, H., Bermudez, T., Kempf, C. L., Valera, D. G., Garcia, A. N., Camp, S. M., Song, J. H., Franco, E., Burt, J. K., Sun, B., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02536-2020 · Cited by 88
Self-citation
Metadata
- Authors
- Goldman, J. L., Sammani, S., Kempf, C., Saadat, L., Letsiou, E., Wang, T., Moreno‐Vinasco, L., Rizzo, A. N., Fortman, J. D., & Garcia, J. G. N.
- Venue
- Pulmonary Circulation
- Publisher
- Wiley
- Published
- 2014-06
- Volume
- 4
- Issue
- 2
- Pages
- 280-288
- ISSN
- 2045-8932 (ISSN-L)
- 2045-8940
- OpenAlex
- W1984705347
- Cited by
- 88
- References
- 6
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.